Skip to main content

New Products

  • Kashi introduces two new vegetarian steam meal options

    BATTLE CREEK, Mich. — Kashi, a natural food and lifestyle company, today announced the addition of two new Steam Meal varieties: Kashi Three Cheese Ravioli and Kashi Mushroom and Asparagus Risotto. Made with the signature Kashi seven whole grain blend and tasty flavor combinations, the new vegetarian Steam Meals offer two servings per bag and provide a convenient and nourishing alternative when a from-scratch meal isn't an option.

  • Sephora launches YOU+Sephora cosmetics collection to benefit charities

    SAN FRANCISCO — Following the launch of Values Inside Out, Sephora's charitable platform has presented the first limited-edition cosmetic collection to benefit its nonprofit partners. 

  • Perfecta Products reformulates Zim's Max-Freeze

    NORTH LIMA, Ohio — Perfecta Products on Tuesday announced the reformulation of Zim's Max-Freeze, which no longer contains such ingredients as parabens, sulfates or coloring. Ingredients now include certified organic ilex, arnica and aloe with a greaseless, stain-free formula.  

  • Advancing pharmacy management service

    Like drinking from a fire hose. That’s one way some pharmacy retailers might describe their efforts to manage the flood of data unleashed every day by their prescription dispensing operations. The goal: to turn that data flow into actionable information they can use to better manage pharmacy workflow and staff resources, boost profitability, reduce customer wait times and make more informed decisions about the capital every retail pharmacy must allocate to technology and staffing.

  • Kathy Ireland helps launch stem-cell derived beauty line

    LOS ANGELES — Kathy Ireland, CEO and chief designer of Kathy Ireland Worldwide and women’s health advocate, is collaborating with board-certified surgeon Dr. David Scharp in bringing to the beauty market a stem cell-derived product brand called Stemáge.

    They note that the unique aspect of the natural skin rejuvenation system is that it targets visible signs of aging through the proprietary use of human Mesenchymal stem cell derivatives, not stem cells but rather active ingredients or derivatives of which stem cells are comprised.

  • More than half of doctor's offices adopt electronic health records

    WASHINGTON — More than half of all healthcare providers who are eligible have received Medicare and Medicaid incentive payments for electronic health records, the Department of Health and Human Services said.

    HHS secretary Kathleen Sebelius said the department had exceeded its goal for 50% of doctor offices and 80% of hospitals to have EHRs by the end of the year. By contrast, the percentage of physicians using EHRs in 2008 was 17%. The American Recovery and Reinvestment Act of 2009 contained incentive programs for adoption of EHRs that went into effect in 2011.

  • J&J plans slew of regulatory filings through 2017

    NEW BRUNSWICK, N.J. — Johnson & Johnson expects to file for Food and Drug Administration approval of more than 10 new drugs over the next four years, the drug maker said Thursday.

    J&J's Janssen Pharmaceutical Cos. highlighted its more than 11 new product launches since 2009 and said it hoped to file with the FDA for more than two-dozen "significant" extensions to its branded drug lines by 2017.

  • FDA approves Sandoz hypertension drug

    PRINCETON, N.J. — The Food and Drug Administration has approved a generic heart-disease drug made by Sandoz, the company said Wednesday.

    Sandoz, the generics division of Swiss drug maker Novartis, announced the approval of candesartan cilexetil tablets, a generic version of AstraZeneca's Atacand.

    The drug is used to treat some types of heart failure in adults with left ventricular systolic dysfunction, as well as high blood pressure in adults and children as young as 1.

    Atacand had sales of $120.3 million in 2012, according to IMS Health.

X
This ad will auto-close in 10 seconds